Dwayne C Jones

USPTO Patent Examiner·Active 2012 to 2022

Dwayne C Jones is a USPTO patent examiner who has handled 30 ex parte reexaminations between 2012 and 2022. These reexams concentrate in Chemistry & Materials, Life Sciences & Consumer, and Mechanical & Manufacturing. ExamPat indexes the full prosecution record for each of these cases, including office-action grounds, certificate outcomes, and downstream PTAB and federal-circuit decisions.

Filings by year

8
12
3
13
3
14
6
15
2
16
3
19
1
20
4
21
1
22

Technology mix

Chemistry & Materials15 (48%)
Life Sciences & Consumer14 (45%)
Mechanical & Manufacturing1 (3%)

Compare against all examiners

Eight side-by-side metrics: case volume, pendency, OAs per reexam, rejection mix, SNQ denial rate, certification rate, and PTAB appeal rate, with a Δ column showing where this examiner runs higher or lower than the corpus.

  • Average and median pendency, both for this examiner and the corpus
  • Rejection basis split (102 / 103 / 112) head-to-head
  • Certification, SNQ denial, and PTAB appeal rates

Certificate outcome distribution

How this examiner's certificates split across the six possible outcomes: all claims confirmed, confirmed with amendment, confirmed with new claims, mixed, or all claims canceled. Includes share comparison to the corpus distribution.

  • Count and share for each of the six outcome buckets
  • Δ vs. corpus distribution in percentage points
  • Useful for setting realistic patent-owner expectations

Event-to-event timing

Median time for this examiner's cases at each prosecution stage, from filing to first office action, filing to NIRC, and filing to certificate, with corpus comparison and sample size.

  • Median in months per transition
  • Side-by-side with the corpus median
  • n column showing how many of this examiner's cases completed each transition

vs. all examiners

Certificate outcome distribution

Event-to-event timing (median)

Recent reexaminations (showing 25 of 30)

Control #FiledPatentTitlePendencyStatus
90/015,012Apr 21, 202211,129,912RADIOPHARMACEUTICAL AND METHODS11 moClosed
90/014,929Dec 22, 20218,435,570NITRATE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS14 moClosed
90/014,822Aug 9, 20218,197,875TASTE MODIFIERS COMPRISING A CHLOROGENIC ACID11 moClosed
90/014,726Apr 13, 202110,973,898Gel for Treating Infectious Bronchitis17 moClosed
90/014,657Jan 22, 202110,894,721WATER-SOLUBLE ELECTROLYZED/SOLVOLYZED CLINOPTILOLITE FRAGMENTS AND NUTRACEUTICAL, PHARMACEUTICAL, AND ENVIRONMENTAL PRODUCTS BASED THEREON13 moClosed
90/014,597Oct 26, 20207,872,072Branched Polymers and their Conjugates14 moClosed
90/014,390Oct 16, 201910,131,682HYDROPHILIC LINKERS AND THEIR USES FOR CONJUGATION OF DRUGS TO A CELL BINDING MOLECULES15 moClosed
90/014,321Jun 20, 20199,868,707SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 15 moClosed
90/014,265Feb 18, 20199,517,988PHENOL DERIVATIVE AND PREPARATION METHOD AND USE IN MEDICINE THEREOF7 moClosed
90/013,719Apr 7, 20168,796,001METALLOENZYME INHIBITOR COMPOUNDS12 moClosed
90/020,096Jan 18, 20168,822,438METHODS AND COMPOSITIONS FOR TREATING CANCERClosed
90/020,086Jul 13, 20158,618,179COMPOSITION COMPRISING A PESTICIDE AND AN ALKOXYLATE OF 2-PROPYLHEPTYLAMINE18 moClosed
90/013,542Jul 3, 20158,952,045AMINO ACID COMPOSITIONS17 moClosed
90/013,526Jun 26, 20158,183,288AMINO ACID COMPOUNDS18 moClosed
90/013,525Jun 26, 20158,178,572AMINO ACID COMPOUNDS17 moClosed
90/013,539Jun 26, 20158,466,187AMINO ACID COMPOSITIONS19 moClosed
90/013,516Jun 16, 20158,569,368AMINO ACID COMPOUNDS19 moClosed
90/013,213Apr 11, 20148,674,112Polymorph of a Pharmaceutical10 moClosed
90/013,122Jan 16, 20148,114,900AMORPHOUS CARVEDILOL DIHYDROGEN PHOSPHATE7 moClosed
90/013,107Jan 8, 20146,992,218Method for Obtaining Aqueous Formulations of Oxidation-Sensitive Active Principles20 moClosed
90/012,932Jul 26, 20137,985,414POLYURETHANES FOR OSTEOIMPLANTS9 moClosed
90/012,916Jul 9, 20138,466,187AMINO ACID COMPOSITIONS42 moClosed
90/012,824Mar 30, 20135,690,988PET FOOD COMPOSITION OF IMPROVED PALATABILITY AND A METHOD OF ENHANCING THE PALATABILITY OF A FOOD COMPOSITION40 moClosed
90/012,759Dec 31, 20126,849,595Calorically Dense Nutritional Composition22 moClosed
90/012,720Nov 16, 20125,641,805Topical Ophthalmic Formulations for Treating Allergic Eye Diseases15 moClosed

Get the full reexam analytics

Compare Dwayne C Jones against the full corpus, see the certificate-outcome split, drill into event timing, filter the case list, and export. Free to sign up.